Recombinant human IFN-α inhibits cerebral malaria and reduces parasite burden in mice

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6416-6425

  Vigário, Ana Margarida ^a,b,c,d,e   Belnoue, Elodie ^a,b,c,d,i   Grüner, Anne Charlotte ^a,b,c,d   Mauduit, Marjorie ^a,b,c,d   Kayibanda, Michèle ^a,b,c,d   Deschemin, Jean Christophe ^a,b,c,d   Marussig, Myriam ^f   Snounou, Georges ^g   Mazier, Dominique ^f   Gresser, Ion ^h   Rénia, Laurent ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^f SORBONNE UNIVERSITÉ   (France)

^g MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^h CENTRE DE RECHERCHE DES CORDELIERS   (France)

ⁱ UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT ALPHA INTERFERON; TUMOR NECROSIS FACTOR;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TRANSFUSION; BRAIN BLOOD VESSEL; BRAIN CELL; BRAIN MALARIA; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; FEMALE; LEUKOCYTE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PARASITOSIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SURVIVAL TIME; UPREGULATION;

EID: 34248170726     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6416     Document Type: Article

References (56)

1. Miller, L. H., D. I. Baruch, K. Marsh, and O. K. Doumbo. 2002. The pathogenic basis of malaria. Nature 415: 673-679.
2. Coltel, N., V. Combes, N. H. Hunt, and G. E. Grau. 2004. Cerebral malaria - a neurovascular pathology with many riddles still to be solved, Curr. Neurovasc. Res. 1: 91-110.
3. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5: 722-735.
4. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499.
5. Engwerda, C. R., E. Belnoue, A. C. Gruner, and L. Renia. 2005. Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 297: 103-143.
6. Hearn, J., N. Rayment, D. N. Landon, D. R. Katz, and J. B. De Souza. 2000. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 68: 5364-5376.
7. + T cells in experimental cerebral malaria. J. Immunol. 169: 6369-6375.
8. Menendez, C., A. F. Fleming, and P. L. Alonso. 2000. Malaria-related anaemia. Parasitol Today 16: 469-476.
9. Rosenberg, E. B., G. T. Strickland, S. L. Yang, and G. E. Whalen. 1994. IgM antibodies to red cells and autoimmune anemia in patients with malaria. Am. J. Trop. Med. Hyg. 22: 146-152.
10. Looareesuwan, S., T. M. Davis, S. Pukrittayakamee, W. Supanaranond, V. Desakorn, K. Silamut, S. Krishna, S. Boonamrung, and N. J. White. 1991. Erythrocyte survival in severe falciparum malaria. Acta Trop. 48: 263-270.
11. Weatherall, D. J., and S. H. Abdalla. 1982. The anemia of Plasmodium falciparum malaria. Brit. Med. Bull. 38: 147-151.
12. Clark, I. A., and G. Chaudhri. 1988. Tumor necrosis factor may contribute to the anemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br. J. Haematol. 70: 99-103.
13. Chang, K. H., and M. M. Stevenson. 2004. Malarial anemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int. J. Parasitol. 34: 1501-1516.
14. McGuire, W., J. C. Knight, A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. P. Kwiatkowski. 1999. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 179: 287-290.
15. Othoro, C., A. A. Lal, B. L. Nahlen, D. Koech, A. S. S. Orago, and V. Udhayakumar. 1999. A low interleukin-10 tumor necrosis factor α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in Western Kenya. J. Infect. Dis. 179: 279-282.
16. Kurtzhals, J. A. L., V. Adabayeri, B. Q. Goka, D. B. Akanmori, J. O. Oliver-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1988. Low plasma concentrations of interleukin 10 in severe malarial anemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772.
17. Tzung, S. P., T. C. Mahl, P. Lance, V. Andersen, and S. A. Cohen. 1992. Interferon α prevents endotoxin-induced mortality in mice. Eur. J. Immunol. 22: 3097-3101.
18. Amani, V., M. I. Boubou, S. Pied, M. Marussig, D. Walliker, D. Mazier, and L. Renia, 1998. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect. Immun. 66: 4093-4099.
19. Vigario, A. M., E. Belnoue, A. M. Cumano, M. Marussig, F. Miltgen, I. Landau, D. Mazier, I. Gresser, and L. Renia. Inhibition of Plasmodium yoelii blood-stage malaria by interferon α through the inhibition of the production of its target cell, the reticulocyte. Blood 97: 3966-3971.
20. Taverne, J. Sheikh, N., J. B. De Souza, J. H. L. Playfair, L. Probert, and G. Kollias. 1994. Anemia and resistance to malaria in transgenic mice expressing human tumor necrosis factor. Immunology 82: 397-403.
21. Meister, A., G. Uze, K. E. Mogensen, I. Gresser, M. G. Tovey, M. Grutter, and F. Meyer. 1986. Biological activities and receptor binding of two human recombinant interferons and their hybrids. J. Gen. Virol. 67: 1633-1643.
22. Hulier, E., P. Petour, G. Snounou, M. P. Nivez, F. Miltgen, D. Mazier, and L. Renia. 1396. A method for the quantitative assessment of malaria parasite development in organs of the mammalian host. Mol Biochem. Parasitol. 77: 127-135.
23. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. I. Immunol. Methods 95: 99-105.
24. Mosmann, T. R. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
25. Belnoue, E., F. T. M. Costa, T. Frankenberg, A. M. Vigano, T. Voza, N. Leroy, M. M. Rodrigues, I. Landau, G. Snounou, and L. Renia. 2004. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172: 2487-2495.
26. Franke-Fayard, B., C. J. Janse, M. Cunha-Rodrigues, J. Ramesar, P. Buscher, I. Que, C. Lowik, P. J. Voshol, M. A. den Boer, S. G. van Duinen, et al. 2005. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. USA 102: 11468-11473.
27. Favre, N., C. Da Laperrousaz, B. Ryffel, N. A. Weiss, B. Imhof, W. Rudin, R. Lucas, and P. F. Piguet. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1: 961-968.
28. Li, J., W. L. Chang, G. Sun, H. L. Chen, R. D. Specian, S. M. Berney, D. Kimpel, D. N. Granger, and H. C. van der Heyde. 2003. Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain. J. Investig. Med. 51: 128-140.
29. Rudin, W., H. P. Eugster, G. Bordmann, J. Bonato, M. T. Muller, M. Yamage, and B. Ryffel. 1997. Resistance to cerebral malaria in tumor necrosis factor α/β-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am. J. Pathol. 150: 257-266.
30. Bauer, P. R. H. C. van der Heyde, G. Sun, R. D. Specian, and D. N. Granger. 2002. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 9: 463-470.
31. Gresser, I., D. Guy-Grand, C. Maury, and M. T. Manoury. 1981. Interferon induces peripheral lymphoadenopathy in mice. J. Immunol. 127: 1569-1575.
32. Amani, V., A. M. Vigario, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Renia. 2000. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malirial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30: 1546-1655.
33. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371-1377.
34. Mitchell, A., A. M. Hansen, L. Hee, H. J. Ball, S. M. Potter, J. C. Walker, and N. H. Hunt. 2005. Early cytokine production is associated with protection from murine cerebral malaria. Infect. Immun. 73: 5645-5653.
35. Shear, H. L., R. Srinivasan, T. Nolan, and C. Ng. 1989. Role of IFN-γ in lethal and nonlethal malaria in susceptible and resistant murine hosts. J. Immunol. 143: 2038-2044.
36. Meding, S. J., S. C. Cheng, B. Simon-Haarhaus, and J. Langhorne. 1990. Role of γ interferon during infection with Plasmodium chabaudi chabaudi. Infect. Immun. 58: 3671-3678.
37. van der Heyde, H. C., B. Pepper, J. Batchelder, F. K. Cigel, and W. P. Weidanz. 1997. The time course of selected malarial infections in cytokine-deficient mice. Exp. Parasitol. 85: 206-213.
38. Yoneto, T., T. Yoshimoto, C. R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi. 1999. γ Interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. J. Immunol. 67: 2349-2356.
39. Eguchi, K., A. Kawakami, M. Nakashima, H. Ida, S. Sakito, N. Matsuoka, K. Terada, M. Sakai, Y. Kawabe, T. Fukuda, et al. 1992. Interferon α and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin. Exp. Immunol. 88: 448-454.
40. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170: 2221-2228.
41. Boubou, M. I., A. Collette, D. Voegtle, D. Mazier, P. A. Cazenave, and S. Pied. 1999. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR Vβ8 during experimental cerebral malaria. Int. Immunol. 11: 1553-1562.
42. Yanez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157: 1620-1624.
43. Sun, G., W. L. Chang, J. Li, S. M. Berney, D. Kimpel, and H. C. van der Heyde. 2003. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect. Immun. 71: 6553-6561.
44. Deharo, E., F. Cocquelin, A. G. Chabaud, and I. Landau. 1996. The erythrocytic schizogony of two synchronized strains of Plasmodium berghei, NK65 and ANKA, in normocytes and reticulocytes. Parasitol. Res. 82: 178-182.
45. Broxmeyer, H. E., L. Lu, E. Platzer, C. Feit, L. Juliano, and B. Y. Rubin. 1983. Comparative analysis of the influences of human γ, α and β interferons on human multipotential (CFU-GM) progenitor cells. J. Immunol. 131: 1300-1305.
46. Means, R. T., and S. B. Krantz. 1996. Inhibition of human eryfhroid colony-forming units by interferons α and β: differing mechanisms despite shared receptor. Exp. Hematol. 24: 204-208.
47. Raefsky, E. L., L. C. Platanias, N. C. Zoumbos, and N. S. Young. 1985. Studies of interferon as a regulator of hematopoietic cell proliferation. J. Immunol. 135: 2507-2512.
48. Tarami, T., K. Sawada, N. Sato, S. Kobayashi, H. Takano, T. Yasukouchi, T. Takahashi, S. Sekiguchi, and T. Koile. 1995. Interferon α-induced apoptosis in human erythroid progenitors. Exp. Hematol. 23: 1310-1318.
49. Angulo, I., R. Rodriguez, B. Garcia, M. Medina, J. Navarro, and J. L. Subiza. 1995. Involvement of nitric oxide in marrow-derived natural suppressor activity: its dependence on IFN-γ. J. Immunol. 155: 15-26.
50. Shami, P. J., and J. B. Weinberg. 1996. Differential effects of nitric oxide on erythroid and myeloid colony growth from CD341 human bone marrow cells. Blood 87: 977-982.
51. Zoumbos, N. C., J. Y. Djeu, and N. S. Young. 1984. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J. Immunol. 133: 769-774.
52. Luty, A. J., D. J. Perkins, B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, et al. 2000. Low Interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68: 3909-3915.
53. Ojo-Amaize, E. A., L. S. Salimonu, A. I. Williams, O. A. Akinwolere, R. Shabo, G. V. Alm, and H. Wigzell. 1981. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J. Immunol. 127: 2296-2300.
54. Ronnblom, L., E. A. Ojo-Amaize, L. Franzen, H. Wigzell, and G. V. Alm. 1985. Plasmodium falciparum parasites induce interferon production in human peripheral blood "null" cells in vitro. Parasite Immunol. 5: 165-172.
55. Aucan, C., A. J. Walley, B. J. Hennig, J. Fitness, A. J. Frodsham, L. Zhang, D. P. Kwiatkowski, and A. V. S. Hill. 2003. Interferon α receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia. Genes Immun. 4: 275-282.
56. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, and F. A. Ennis, Jr. 1993. High levels of interferon α in the sera of children with Dengue virus infection. Am. J. Trop. Med. Hyg. 48: 222-229.